Medication info
Aprovel 150 mg (Irbesartan)

Aprovel 150 mg (Irbesartan)

Prescription medicationTabletOral
Ingredient · strength
Irbesartan›150mg / 1 tablet
Manufacturer / importer
Handok Co., Ltd.
Appearance
Oval film-coated tablet that is white or almost white, biconvex on both sides with a heart shape engraved on one side and the number "2872" engraved on the other side.
Packaging
30 tablets (10 tablets/blister × 3), 100 tablets/bottle
Approval status
Active

MFDS item code 200701725 · Approved 2007.02.08 · Insurance code 652100870

Summary

Main use
Treatment of essential hypertension and diabetic nephropathy in patients with type 2 diabetes and hypertension
Who takes it
Adults
Adult dose
This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer 150 mg of irbesartan orally once daily; the dose may be increased to 300 mg if the effect is insufficient. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in special cases (at the start of treatment, in patients receiving hemodialysis, or in elderly patients aged 75 years or older, etc.). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be administered concomitantly. The effect is increased, in particular, when administered in combination with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to initiate oral administration of 150 mg of this medicine once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be administered concomitantly to achieve the target blood pressure. ○ Elderly patients Dose adjustment is generally not necessary, but an initial dose of 75 mg should be considered for patients aged 75 years or older. ○ Patients with renal impairment Dose adjustment is generally not necessary, but an initial dose of 75 mg should be considered for patients receiving hemodialysis. ○ Patients with hepatic impairment Dose adjustment is generally not necessary in patients with mild to moderate hepatic impairment, but it is recommended not to exceed 150 mg per day. However, there is no clinical experience in patients with severe hepatic impairment.

Ingredients

Manufacturer
Handok Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and diabetic nephropathy in patients with type 2 diabetes and hypertension

  • Essential hypertension
  • hypertension
  • nephropathy in patients with type 2 diabetes
View approved original text

This medication is used to control blood pressure in patients with essential hypertension. It also helps to prevent or slow the progression of nephropathy in patients with hypertension and type 2 diabetes. Therefore, it is used to improve various symptoms associated with hypertension and maintain kidney health.

How to take

Adult dose

This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer 150 mg of irbesartan orally once daily; the dose may be increased to 300 mg if the effect is insufficient. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in special cases (at the start of treatment, in patients receiving hemodialysis, or in elderly patients aged 75 years or older, etc.). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be administered concomitantly. The effect is increased, in particular, when administered in combination with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to initiate oral administration of 150 mg of this medicine once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be administered concomitantly to achieve the target blood pressure. ○ Elderly patients Dose adjustment is generally not necessary, but an initial dose of 75 mg should be considered for patients aged 75 years or older. ○ Patients with renal impairment Dose adjustment is generally not necessary, but an initial dose of 75 mg should be considered for patients receiving hemodialysis. ○ Patients with hepatic impairment Dose adjustment is generally not necessary in patients with mild to moderate hepatic impairment, but it is recommended not to exceed 150 mg per day. However, there is no clinical experience in patients with severe hepatic impairment.

Precautions

This medication can cause serious harm to the fetus and newborn if administered to pregnant women, so it should be discontinued immediately if pregnancy is confirmed. Additionally, it should not be used by individuals allergic to this medication or its ingredients, patients with severe liver impairment, hereditary angioedema patients, or women who are pregnant or breastfeeding. Patients with certain genetic conditions such as galactose intolerance should also avoid this medication. Diabetic patients or those with severely impaired kidney function should not take this medication with certain drugs, and patients with diabetic nephropathy who are taking ACE inhibitors should be avoided. Caution is required for the elderly, patients with hyperkalemia, and those with poor liver function, and patients with heart or vascular diseases should be cautious of excessively low blood pressure. Patients at risk for rapid drops in blood pressure or worsening kidney function require particular caution. While taking this medication, rare side effects such as angioedema (swelling of the face, lips, or tongue), hyperkalemia, shock, renal failure, liver dysfunction, hypoglycemia, and serious muscle-related side effects may occur, so immediate consultation with a physician is necessary if abnormal symptoms arise. Patients with poor liver function should not exceed 150 mg per day, and severe liver impairment patients should not use this medication. It is advisable not to take this medication within 24 hours prior to surgery. Patients with reduced blood volume may experience symptoms of hypotension, so their condition or diuretic dosage should be adjusted before taking it. Patients with vascular issues in the kidneys should avoid this medication if possible, as kidney function may deteriorate rapidly upon ingestion. Patients with diabetic nephropathy or heart failure, whose kidney function is unstable, should have their serum potassium and creatinine levels monitored regularly. The blood pressure-lowering effect of this medication may be somewhat weaker in Black patients. Dizziness or fatigue may occur during treatment, necessitating caution when driving or operating machinery. Patients with hypoglycemic symptoms or those undergoing diabetes treatment should consult a physician or pharmacist before use and adjust blood glucose and medication dosages as needed. This medication may interact with other blood pressure medications, diuretics, potassium supplements, lithium, and non-steroidal anti-inflammatory drugs, so it is vital to inform your provider if you are taking any other medications. In particular, concomitant use of ACE inhibitors or aliskiren increases the risk of hypotension, hyperkalemia, and renal dysfunction, so it is not recommended, and blood pressure and kidney function should be closely monitored if used together. Safety in pediatric patients has not been established, so it should be administered to children with caution. In case of overdose, hypotension and arrhythmias may occur, so if symptoms arise, immediate notification to healthcare personnel is necessary for appropriate treatment. This medication should be stored out of reach of children and should not be transferred to another container.

Side effects

  • Upper respiratory infection
  • sinus abnormality
  • influenza
  • pharyngitis
  • rhinitis
  • musculoskeletal pain
  • myalgia
  • headache
  • dizziness
  • fatigue
Show 121 more
  • diarrhea
  • cough
  • nausea
  • vomiting
  • musculoskeletal injury
  • chest pain
  • dyspepsia
  • heartburn
  • edema
  • abdominal pain
  • rash
  • tachycardia
  • anxiety
  • irritability
  • upper urinary tract infection
  • fever
  • chills
  • facial edema
  • arm edema
  • flushing
  • heart murmur
  • myocardial infarction
  • angina
  • arrhythmia
  • conduction abnormality
  • cardiac-respiratory arrest
  • heart failure
  • hypertensive crisis
  • pruritus
  • dermatitis
  • petechiae
  • erythema
  • urticaria
  • sexual dysfunction
  • changes in sexual function
  • gout
  • constipation
  • oral lesions
  • gastroenteritis
  • abdominal bloating
  • limb edema
  • muscle stiffness
  • arthritis
  • muscle weakness
  • joint stiffness
  • bursitis
  • sleep disorders
  • paralysis
  • hypersomnia
  • mood disorder
  • depression
  • sensory disturbances
  • tremors
  • transient ischemia
  • cerebrovascular accident
  • abnormal urination
  • prostate abnormality
  • nasal bleeding
  • bronchitis
  • congestion
  • pulmonary congestion
  • dyspnea
  • wheezing
  • visual impairment
  • auditory disturbances
  • ear infection
  • ear pain
  • conjunctivitis
  • eyelid abnormality
  • ear abnormality
  • dizziness
  • orthostatic dizziness
  • orthostatic hypotension
  • hyperkalemia
  • rash
  • urticaria
  • angioedema
  • anaphylactic shock
  • debility
  • dyspepsia
  • tinnitus
  • increased plasma creatine kinase
  • arthralgia
  • hepatitis
  • hepatic dysfunction
  • renal insufficiency
  • psoriasis
  • phototoxic reaction
  • anemia
  • thrombocytopenia
  • hypoglycemia
  • shock
  • syncope
  • loss of consciousness
  • renal failure
  • hepatic impairment
  • jaundice
  • rhabdomyolysis
  • weakness
  • increased creatine kinase
  • elevated serum and urinary myoglobin
  • palpitations
  • constipation
  • dyspnea
  • sensory impairment
  • hypertriglyceridemia
  • insomnia
  • dysgeusia
  • thirst
  • abdominal bloating
  • oral bleeding
  • increased sputum
  • decreased HDL
  • increased salivation
  • surface
  • neutropenia
  • leukopenia
  • erectile dysfunction
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture from entering. Additionally, it should be kept in a cool, dry place below 30 degrees Celsius.

Appearance and packaging

Appearance

Oval film-coated tablet that is white or almost white, biconvex on both sides with a heart shape engraved on one side and the number "2872" engraved on the other side.

Package unit

30 tablets (10 tablets/blister × 3), 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.